https://www.npr.org/sections/health-shots/2019/05/12/722216512/bottle-of-lies-exposes-the-dark-side-of-the-generic-drug-boom

>Other Ranbaxy plants squeaked through regulatory inspections entirely, like the plant that manufactured generic Lipitor, the blockbuster cholesterol drug. Less than a year after that plant passed an inspection in 2012, Ranbaxy admitted that some of the millions of generic Lipitor pills already dispensed in the U.S. were suffused with tiny shards of blue glass.

Yikes.

>The situation was even worse in Africa, where many manufacturers shipped their lowest-quality drugs. Some were completely counterfeit, with independent lab analysis showing no active ingredients whatsoever. Those that had active ingredients often didn't have enough, and doctors would need to prescribe anywhere from double to 10 times the typical dose to achieve an effect, according to Eban.

So they were basically selling placebos to African countries?

>Eventually, Ranbaxy, as a company, was brought to justice. But none of the individuals responsible were prosecuted

Of course they weren't. And I wouldn't call a $200m fee justice when it's a billion dollar company